ZA954796B - Diamines - Google Patents

Diamines

Info

Publication number
ZA954796B
ZA954796B ZA954796A ZA954796A ZA954796B ZA 954796 B ZA954796 B ZA 954796B ZA 954796 A ZA954796 A ZA 954796A ZA 954796 A ZA954796 A ZA 954796A ZA 954796 B ZA954796 B ZA 954796B
Authority
ZA
South Africa
Prior art keywords
diyl
pct
phenylene
cyclohexane
signifies
Prior art date
Application number
ZA954796A
Other languages
English (en)
Inventor
Werner Hofheinz
Werner Leupin
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA954796B publication Critical patent/ZA954796B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ZA954796A 1994-06-17 1995-06-09 Diamines ZA954796B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH192894 1994-06-17

Publications (1)

Publication Number Publication Date
ZA954796B true ZA954796B (en) 1996-01-03

Family

ID=4221871

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA954796A ZA954796B (en) 1994-06-17 1995-06-09 Diamines

Country Status (17)

Country Link
US (1) US5736557A (zh)
EP (1) EP0765313B1 (zh)
JP (1) JPH10501540A (zh)
CN (1) CN1120156C (zh)
AT (1) ATE247642T1 (zh)
AU (1) AU691306B2 (zh)
CA (1) CA2192203A1 (zh)
DE (1) DE69531543T2 (zh)
DK (1) DK0765313T3 (zh)
ES (1) ES2204956T3 (zh)
IL (1) IL114099A (zh)
MX (1) MX9606382A (zh)
MY (1) MY115176A (zh)
NZ (1) NZ288223A (zh)
PT (1) PT765313E (zh)
WO (1) WO1995035287A1 (zh)
ZA (1) ZA954796B (zh)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR199800854T2 (xx) * 1995-11-16 1998-08-21 F.Hoffmann-La Roche Ag Antis�tma kinolin t�revleri.
US6174897B1 (en) 1996-10-25 2001-01-16 Bayer Aktiengesellschaft Bis-(quinolyl)-diamines
US5866562A (en) * 1996-10-25 1999-02-02 Bayer Aktiengesellschaft Ring-bridged bis-quinolines
US5882996A (en) * 1997-10-14 1999-03-16 Industrial Technology Research Institute Method of self-aligned dual damascene patterning using developer soluble arc interstitial layer
WO2000076982A1 (en) * 1999-06-16 2000-12-21 University Of Iowa Research Foundation Antagonism of immunostimulatory cpg-oligonucleotides by 4-aminoquinolines and other weak bases
KR100520168B1 (ko) * 1999-06-21 2005-10-10 주식회사 하이닉스반도체 화학증폭형 레지스트에 첨가되는 새로운 페닐렌디아민계 유도체
DE10008522A1 (de) * 2000-02-24 2001-09-06 Hassan Jomaa Verwendung von 2-PHenylendiaminderivaten zur Behandlung von Infektionen
GB0112834D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
US6818772B2 (en) * 2002-02-22 2004-11-16 Abbott Laboratories Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
WO2003070244A1 (en) * 2002-02-22 2003-08-28 Abbott Laboratories Antagonist of melanin concentrating hormone and their uses
WO2007056580A2 (en) * 2005-11-08 2007-05-18 Pharmadyn, Inc. Methods and compositions for treating diseases associated with pathogenic proteins
WO2007059372A2 (en) * 2005-11-09 2007-05-24 St. Jude Children's Research Hospital Use of chloroquine to treat metabolic syndrome
US20110045100A1 (en) * 2008-03-05 2011-02-24 Georgetown University Antimalarial Quinolines and Methods of Use Thereof
US8481543B2 (en) 2008-11-18 2013-07-09 Oregon Health & Science University Compounds for treating parasitic disease
EP2470013A4 (en) * 2009-08-27 2013-05-01 Us Health COMPOUNDS FOR THE TREATMENT OF MALARIA AND FOR PREVENTING MALARIA TRANSMISSIONS
EP2394982A1 (en) 2010-06-08 2011-12-14 Lonza Ltd. Process for the preparation of cis-diaminocycloalkanes
EP2394981A1 (en) 2010-06-08 2011-12-14 Lonza Ltd. Process for the preparation of cis-diaminocycloalkanes
EA023927B1 (ru) 2010-06-22 2016-07-29 Дна Терапьютикс ОПТИМИЗИРОВАННАЯ С ПОМОЩЬЮ ЭНДОСОМОЛИТИЧЕСКИХ СРЕДСТВ СИСТЕМА ДОСТАВКИ in vivo КОНЪЮГАТОВ НУКЛЕИНОВОЙ КИСЛОТЫ
EP2527440A1 (en) 2011-05-27 2012-11-28 Institut Curie Cancer treatment by combining DNA molecules mimicking double strand breaks with hyperthermia
WO2015133280A1 (ja) * 2014-03-03 2015-09-11 公立大学法人名古屋市立大学 抗マラリア活性化合物及び抗マラリア薬
EP3224235B1 (de) 2014-11-25 2018-11-14 Basf Se Verfahren zur herstellung von cis- und trans-angereichertem mdach
MA45328A (fr) 2016-04-01 2019-02-06 Avidity Biosciences Llc Compositions acide nucléique-polypeptide et utilisations de celles-ci
WO2018003708A1 (ja) * 2016-06-28 2018-01-04 大日本印刷株式会社 化合物、及びその中間体
JP2020505330A (ja) 2017-01-06 2020-02-20 アビディティー バイオサイエンシーズ エルエルシー エクソンスキッピングを誘導する核酸ポリペプチド組成物および方法
GB201711809D0 (en) 2017-07-21 2017-09-06 Governors Of The Univ Of Alberta Antisense oligonucleotide
MX2020003596A (es) 2017-10-04 2020-07-22 Avidity Biosciences Inc Composiciones de acido nucleico-polipeptido y usos de las mismos.
AU2018378812A1 (en) 2017-12-06 2020-07-09 Avidity Biosciences, Inc. Compositions and methods of treating muscle atrophy and myotonic dystrophy
SG11202106593UA (en) 2018-12-21 2021-07-29 Avidity Biosciences Inc Anti-transferrin receptor antibodies and uses thereof
CN113412258A (zh) 2019-01-18 2021-09-17 阿斯利康(瑞典)有限公司 Pcsk9抑制剂及其使用方法
WO2020247782A1 (en) 2019-06-06 2020-12-10 Avidity Biosciences, Inc. Nucleic acid-polypeptide compositions and uses thereof
IL296387B1 (en) 2020-03-19 2024-04-01 Avidity Biosciences Inc Preparations and methods for the treatment of facial, back and arm muscle atrophy
WO2021195469A1 (en) 2020-03-27 2021-09-30 Avidity Biosciences, Inc. Compositions and methods of treating muscle dystrophy
EP4251746A1 (en) 2020-11-30 2023-10-04 Cellectis SA Use of aminoquinoline compounds for higher gene integration
KR20240055874A (ko) 2021-09-16 2024-04-29 어비디티 바이오사이언시스 인크. 안면견갑상완 근이영양증을 치료하는 조성물 및 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2816893A (en) * 1957-12-17 Improvements in or relating to
US2901484A (en) * 1957-03-04 1959-08-25 Abbott Lab Bis-quinoliniums
US5510356A (en) * 1991-10-03 1996-04-23 University Of Nebraska Board Of Regents Bisquinolines and processes for their production and use to treat malaria

Also Published As

Publication number Publication date
DK0765313T3 (da) 2003-12-08
DE69531543D1 (de) 2003-09-25
AU2736995A (en) 1996-01-15
AU691306B2 (en) 1998-05-14
WO1995035287A1 (en) 1995-12-28
IL114099A0 (en) 1995-10-31
US5736557A (en) 1998-04-07
NZ288223A (en) 1997-11-24
CA2192203A1 (en) 1995-12-28
CN1153513A (zh) 1997-07-02
EP0765313B1 (en) 2003-08-20
PT765313E (pt) 2003-11-28
MY115176A (en) 2003-04-30
ATE247642T1 (de) 2003-09-15
JPH10501540A (ja) 1998-02-10
DE69531543T2 (de) 2004-06-24
CN1120156C (zh) 2003-09-03
MX9606382A (es) 1997-03-29
IL114099A (en) 2000-02-29
ES2204956T3 (es) 2004-05-01
EP0765313A1 (en) 1997-04-02

Similar Documents

Publication Publication Date Title
ZA954796B (en) Diamines
DE69527839T2 (de) Tropan-2-aldoximderivate als neurotransmitter "reuptake" inhibitoren
GR3036606T3 (en) Pyrimidine or triazine carboxylic acid derivatives to be used as medicaments
ES2006619A6 (es) Un metodo para preparar derivados de piridil-y pirimidil-piperazinas.
ZA941739B (en) Amide derivatives
ZA9429B (en) Pyrrolidine derivatives their preparation and medicaments containing them
IL112763A0 (en) New n-benzoylmethyl-piperidines
HU9502067D0 (en) N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders
TW282458B (zh)
HU9500710D0 (en) Ureido-acetamide derivatives, preparation thereof and drugs containing same
ES2084485T3 (es) Procedimiento para la preparacion de amino-2 nitro-7 benzotiazoles.
HU9603205D0 (en) Intermediate for preparing a pharmaceutically active compound
MX9705378A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de la obesidad.